Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient’s bedside

1

Dendritic cells (DCs) are crucial for antitumor immunity and are a focus for developing cancer immunotherapy.
2

DC function is highly context-dependent, influenced by the tumor microenvironment and specific cellular compartments.
3

Therapeutic strategies must consider the generation and functional programming of different DC populations for effective immunotherapy.
4

DC dysfunction varies across malignancies, necessitating tailored therapeutic designs aligned with each cancer's biology.
5

Future advances in DC-based immunotherapy will rely on improved patient stratification and integration with other treatment modalities.

1